BALA CYNWYD, Pa., Jan. 15, 2016 /PRNewswire/ -- Law Office of Brodsky & Smith, LLC announces an investigation of Clovis Oncology, Inc. ("Clovis" or the "Company") (Nasdaq -CLVS- News) for potential violations of federal securities laws and breaches of the Clovis Board's fiduciary duties.
Click here to learn more about the investigation http://brodsky-smith.com/1022-clvs-clovis-oncology-inc.html, or call: 877-534-2590. There is no cost or obligation to you.
The investigation concerns a securities class action lawsuit commenced in the United States District Court for the District of Colorado. The complaint alleges that the Defendants made false and misleading statements including (1) failing to disclose that its New Drug Application ("NDA") submitted to the FDA for its lung cancer treatment rociletnib contained immature data sets (2) Clovis' Breakthrough Therapy designation submission contained immature data sets based primarily on unconfirmed responses; (3) Clovis presented interim data publicly on unconfirmed responses; (4) as the efficacy data matured, the number of patents with unconfirmed response who converted to confirmed response was lower than expected; and (5) Clovis's NDA was likely to be delayed and/or rejected by the FDA. As a result, on November 16, 2015 shares of Clovis stock fell over 69%.
If you purchased shares of Clovis common stock between October 31, 2013 and November 13, 2015, and wish to discuss the investigation, or if you have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC before January 19 , 2016, who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at firstname.lastname@example.org, by visiting http://brodsky-smith.com/1022-clvs-clovis-oncology-inc.html, or calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and successfully recovered millions of dollars for our clients and shareholders.
Attorney advertising. Prior results do not guarantee a similar outcome.
SOURCE Brodsky & Smith, LLC